Abstract
Context Early-onset thyroid cancer incidence has been increasing, raising concerns about contributing factors.
Objective We aimed to investigate the role of nitrate contamination in drinking water as a contributor to early-onset thyroid cancer incidence.
Design We designed an ecological study, analyzing population-based data from the National Program of Cancer Registries. We quantified the association between nitrate exposure and early-onset thyroid cancer with a set of Poisson generalized estimating equations (GEE). Analyses adjusted for current and 7-year lagged obesity rates and access to screening.
Setting Our nationwide study includes data from all 50 states in the U.S.
Patients Patients between ages 0-14, 15-39, 40-59 who were diagnosed with thyroid cancer between 2003 and 2022.
Exposures States were categorized into two groups based on predicted groundwater nitrate levels. States with nitrate < 2.0 mg/L were classified as “Low”, and states with levels >= 2.0 mg/L as “High”.
Main Outcome Measures Population adjusted cases of thyroid cancer incidence, with patients grouped by age and sex.
Results For the 0-14 or 40-59 age groups, we found no differences in thyroid incidence by nitrate exposure. For ages 15-39, there were 41.6 (CI: 6.2,77.1) more cases in high nitrate states, reflecting an 18.5% difference. Stratified by sex, in the 15-39 age group of females had 32.7 (CI: 6.3,59.1) more cases and males had 8.2 (CI: 0.1,16.4) more cases, reflecting a 17.8% and 20.4% difference respectively.
Conclusions Elevated exposure to groundwater nitrate may be a significant preventable contributor to thyroid cancer in adolescents and young adults.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email: christina.zanazanian{at}dmu.edu;
Funding: none
DISCLOSURE SUMMARY: no conflicts to disclose.
Data Availability
Data Availability: All analytic data for this study is shared as a supplemental file.
